Colix Injection NSAID for the alleviation of inflammation and pain of the gastrointestinal, musculoskeletal and ocular systems and the treatment of endotoxic shock


Flunixin Meglumine equivalent to 50 mg/mL Flunixin


100mL vial


Equine - For the alleviation of inflammation and pain associated with musculoskeletal disorders and for the alleviation of visceral pain and inflammation associated with colic. Also aids the normalisation of peristalsis. For the treatment of inflammatory ocular conditions such as uvelitis and pre- and post-eye surgery. Flunixin also reduces the haemodynamic changes associated with endotoxaemia/endotoxic shock.

Bovine - As an aid in the management of acute respiratory disease in cattle. As an aid in the management of “downer cow” syndrome.

Swine - As an aid in the treatment of mastitis, metritis, agalactia syndrome (MMA or lactational failure) in sows.

Canine - As supportive therapy for arthritis, heat stroke and accident cases.


Injection reactions may develop following intramuscular injections in horses and are best avoided.

Equine - Musculoskeletal disorders: 1.1 mg per kg (1mL/45kg) bodyweight one to two times daily by intravenous injection injection for up to 5 days. Alleviation of pain associated with colic - 1.1 mg per kg bodyweight I.V administration is recommended for prompt relief. May be repeated if signs of colic recur. Cause of colic should be determined and treated with concomitant therapy.

Bovine - Infectious respiratory conditions, “downer cow” Syndrome - 2.2 mg/kg I.V. (2mL/45kg bodyweight). Once daily dosage for 1-3 days. Concomitant anti-infective therapy required in the presence of bacterial infections. Oxytetracycline and tylosin are compatible with flunixin. Separate injections must be given. Footrot and musculoskeletal indications, visceral pain (colic) - 1.1mg/kg I.M. or I.V.

Swine - MMA syndrome: 2.2 mg/kg (2 mL/45kg) by deep I.M. injection (5 cm). One or two injections twelve hours apart.

Canine - 1.1 mg per kg bodyweight I.V. (0.2 mL/9 kg bodyweight) once daily for 2-3 days. Dose rate should not be exceeded.


This product is contraindicated for use in cats. The safe use of Colix in pregnant, lactating or breeding dogs has not been established. In the absence of any specific studies in pregnant target animals such use is not recommended. Avoid intramuscular administration in the horse. Concurrent use with other anti-inflammatory drugs should be avoided.


Export slaughter interval - this product does not have an ESI established. For advice on the ESI, contact Randlab on (02) 9534 8207 before using the product.


Meat (cattle, pigs) - DO NOT USE less than 7 days before slaughter for human consumption.

Meat (horses) - DO NOT USE less than 28 days before slaughter for human consumption.

Milk - Milk collected from cows within 36 hours (3 milkings) following treatment MUST NOT BE USED for human consumption or processing. The milk should not be feed to bobby calves.


If used in performance animals, the regulations of the relevant authorities regarding medication should be observed.


If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126 or in New Zealand 0800 764 766.


Dispose of empty container by wrapping with paper and putting in garbage. Discarded needles/sharps should immediately be placed in a designated and appropriately labelled “sharps” container..


Store below 30C (Room Temperature). Do not freeze.


APVMA Approval No. 68287/57947 (Australia)

ACVM No. A011471 (New Zealand)

© Randlab 2019 | All rights reserved